Charge-Driven Fibril Recognition and Covalent Disruption of Aβ42 by Paddlewheel Diruthenium Complexes

Abstract The inhibition of Aβ42 (β-amyloid) fibril formation is a key therapeutic strategy in Alzheimer’s disease research. Paddlewheel diruthenium complexes have shown promising activity against Aβ42 aggregation and preformed fibril disaggregation, yet their molecular mode of action remains poorly understood. In this work, we perform atomistic simulations to explore how charge modulation influences the interactions of three analogous paddlewheel diruthenium complexes, the parent neutral complex [Ru2Cl(D-p-FPhF)(O2CCH3)3], and its anionic [Ru2Cl2(D-p-FPhF)(O2CCH3)3]− and cationic [Ru2(D-p-FPhF)(O2CCH3)3]+ counterparts (D-p-FPhF– is the N,N′-bis(4-fluorophenyl)formamidinato ligand) with Aβ42. Our results indicate that electrostatic tuning governs binding affinity and the extent of interaction across the Aβ42 fibril surface. As the complexes’ charge changes from −1 to +1, the interaction pattern shifts from localized contacts to widespread, multi-site engagement encompassing key charged, aromatic, and hydrophobic regions of Aβ42. This enhanced binding correlates with longer-lived, thermodynamically stable interactions at the fibril interface, which effectively lower the free energy penalty for fibril disassembly. Overall, our findings propose a mechanism in which charge-dependent activation through ligand exchange enhances fibril recognition and promotes disruptive binding modes, demonstrating the potential of charge-tunable diruthenium complexes as therapeutic modulators of Aβ42 fibril stability.

Authors

Institutions

Publication Details

Journal
Journal of Chemical Information and Modeling
Published
2026-09-17
DOI
https://doi.org/10.1021/acs.jcim.6c02388
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Charge-Driven Fibril Recognition and Covalent Disruption of Aβ42 by Paddlewheel Diruthenium Complexes

Jorge R. Espinosa, Santiago Herrero, Aarón Terán, Daniela Marasco et al.
Journal of Chemical Information and Modeling
Alzheimer's disease research and treatments
article

Charge-Driven Fibril Recognition and Covalent Disruption of Aβ42 by Paddlewheel Diruthenium Complexes

Jorge R. Espinosa, Santiago Herrero, Aarón Terán, Daniela Marasco, Antonello Merlino, Andrés R. Tejedor, Alejandro Feito, Alberto Ocana
article en

Abstract

Abstract The inhibition of Aβ42 (β-amyloid) fibril formation is a key therapeutic strategy in Alzheimer’s disease research. Paddlewheel diruthenium complexes have shown promising activity against Aβ42 aggregation and preformed fibril disaggregation, yet their molecular mode of action remains poorly understood. In this work, we perform atomistic simulations to explore how charge modulation influences the interactions of three analogous paddlewheel diruthenium complexes, the parent neutral complex [Ru2Cl(D-p-FPhF)(O2CCH3)3], and its anionic [Ru2Cl2(D-p-FPhF)(O2CCH3)3]− and cationic [Ru2(D-p-FPhF)(O2CCH3)3]+ counterparts (D-p-FPhF– is the N,N′-bis(4-fluorophenyl)formamidinato ligand) with Aβ42. Our results indicate that electrostatic tuning governs binding affinity and the extent of interaction across the Aβ42 fibril surface. As the complexes’ charge changes from −1 to +1, the interaction pattern shifts from localized contacts to widespread, multi-site engagement encompassing key charged, aromatic, and hydrophobic regions of Aβ42. This enhanced binding correlates with longer-lived, thermodynamically stable interactions at the fibril interface, which effectively lower the free energy penalty for fibril disassembly. Overall, our findings propose a mechanism in which charge-dependent activation through ligand exchange enhances fibril recognition and promotes disruptive binding modes, demonstrating the potential of charge-tunable diruthenium complexes as therapeutic modulators of Aβ42 fibril stability.

Journal of Chemical Information and Modeling
Universidad Complutense de Madrid (ES), University of Cambridge (GB), Spanish National Cancer Research Centre (ES), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES), Federico II University Hospital (IT), Casa de Velázquez (ES), University of Naples Federico II (IT)
Affordable and clean energy
Openalex Percentile: Top 11%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.